1 - L1_BEVACIZUMAB (DOE)
Deadline:24 Nov 2024, 23:00 CET
Tender information
TED EUVitoria-Gasteiz, Spain
- Type
- 16
- Procedure
- open
- Ref. number
- 641577-2024
- Estimated value
- 8,809,090 EUR
- CPV
- 33600000
Suministro de Bevacizumab (DOE),Vinorelbina (DOE),Linezolid (DOE),Dexketoprofeno (DOE),Azitromicina (DOE),Asoc Lopinav/Ritonavir (DOE), Ondansetrón, Bromuro Ipratropio, Sapropterina y Hierro Sacarosa